Evidence map›Paper›PMID 41603379›Full record

ReviewThe Journal of clinical endocrinology and metabolism2026

Is adrenal adenoma to carcinoma transformation possible?-Illustrative cases and literature review.

Sophie Howarth, James MacFarlane, Lisa Yang, Ines Harper, Ashley Shaw, Yasir S Elhassan, Vasilis Kosmoliaptsis, Mark Gurnell, Cristina L Ronchi, Ruth T Casey

Abstract readCase ReportsReview
In one paragraph

Review in The Journal of clinical endocrinology and metabolism, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Sophie HowarthCambridge Endocrine Molecular Imaging Group, Metabolic Research Laboratories, Institute of Metabolic Science, Addenbrooke's Hospital, Hills Road, Cambridge CB2 0QQ, UK.ORCID 0000-0001-7169-2356
James MacFarlaneCambridge Endocrine Molecular Imaging Group, Metabolic Research Laboratories, Institute of Metabolic Science, Addenbrooke's Hospital, Hills Road, Cambridge CB2 0QQ, UK.ORCID 0000-0001-6937-2775
Lisa YangDepartment of Endocrinology, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK.
Ines HarperDepartment of Radiology, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK.
Ashley ShawDepartment of Radiology, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK.
Yasir S ElhassanDepartment of Metabolism and Systems Science, College of Medicine and Health, University of Birmingham, Birmingham B15 2WB, UK.
Vasilis KosmoliaptsisDepartment of Surgery, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK.
Mark GurnellCambridge Endocrine Molecular Imaging Group, Metabolic Research Laboratories, Institute of Metabolic Science, Addenbrooke's Hospital, Hills Road, Cambridge CB2 0QQ, UK.
Cristina L RonchiDepartment of Metabolism and Systems Science, College of Medicine and Health, University of Birmingham, Birmingham B15 2WB, UK.ORCID 0000-0001-5020-2071
Ruth T CaseyCambridge Endocrine Molecular Imaging Group, Metabolic Research Laboratories, Institute of Metabolic Science, Addenbrooke's Hospital, Hills Road, Cambridge CB2 0QQ, UK.ORCID 0000-0003-4058-3135

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

contextA minority of adrenocortical carcinomas (ACC) demonstrate indolent growth but can usually be identified by radiological characteristics such as inhomogeneity or high unenhanced density. However, cases of ACC developing from a lesion with benign radiological features at baseline and histopathological reports of ACC embedded within an adrenal adenoma have emerged. The adenoma to carcinoma transition in the adrenal gland may be a possible, albeit rare, phenomenon. CASE DESCRIPTIONS: We present 2 cases from 2 tertiary centers in the United Kingdom who were diagnosed with an adrenal adenoma and showed stable radiological characteristics over 14 years and 11 years, respectively, prior to a rapid enlargement of the lesion and diagnosis with ACC. We review the existing literature and describe 4 additional cases who met radiological criteria for an adrenal adenoma and demonstrated prolonged lesion stability (>5 years) on serial imaging prior to a subsequent diagnosis of ACC. We also identify 4 case reports of patients with radiologically indeterminate adrenal nodules at baseline who demonstrated prolonged size stability for up to 10 years prior to an accelerated growth phase and diagnosis with ACC. There was no significant difference in the average time to ACC diagnosis seen in those with benign radiological features at baseline (10.5 years, n = 6) and those with radiologically indeterminate nodules at baseline (8.75 years, n = 4, P = .39).

conclusionAdrenal lesions with baseline benign radiological characteristics can very rarely transpire to be ACC. Prolonged dimensional stability cannot be considered a reassuring feature in isolation when assessing radiologically indeterminate adrenal lesions.

Indexed as

AdenomaAdrenal Cortex NeoplasmsAdrenocortical AdenomaAdrenocortical CarcinomaCell Transformation, NeoplasticFemaleHumansMaleMiddle Agedadrenal adenomaadrenal incidentalomaadrenocortical carcinoma

Identifiers

PMID41603379
PMCPMC13271790

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.